文献速递眼底病与葡萄膜炎青光眼神经眼科

视网膜血氧测定发现视网膜与脑部疾病的新型生物标志物

Retinal Oximetry Discovers Novel Biomarkers in Retinal and Brain Diseases.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

本文综述视网膜血氧测定在糖尿病视网膜病变、视网膜中央静脉阻塞、视网膜色素变性、青光眼和阿尔茨海默病中的应用。该技术基于分光光度眼底成像,无创快速安全地测量视网膜小动脉和小静脉的血氧饱和度,可检测缺血或萎缩导致的氧代谢变化,作为视网膜萎缩程度的客观代谢指标。

要点

  • 糖尿病视网膜病变中静脉血氧饱和度升高、动静脉差减小,且与眼底照片常规分级的严重程度相关。
  • 视网膜中央静脉阻塞时静脉阻塞导致缺氧,视网膜血氧测定可直接测量以确认诊断和评估严重程度。
  • 在萎缩性疾病如视网膜色素变性和青光眼中,视网膜氧消耗降低,血氧测定与视野损害和视网膜萎缩相关。

核心结论

  • 视网膜血氧测定是一种新型无创技术,开辟了视网膜代谢成像领域。
  • 已发现视网膜和中枢神经系统代谢性、缺血性和萎缩性疾病中的生物标志物。

研究设计与样本

  • 综述:基于分光光度眼底成像的视网膜血氧测定,无创、快速、安全地测量视网膜小动脉和小静脉的血氧饱和度。

主要发现

  • 糖尿病视网膜病变中静脉血氧饱和度升高、动静脉差减小,两者均与眼底照片常规分类的糖尿病视网膜病变严重程度相关。
  • 视网膜中央静脉阻塞中静脉阻塞导致缺氧,视网膜血氧测定可直接测量以确认诊断和测量严重程度。
  • 在糖尿病视网膜病变和视网膜中央静脉阻塞中,氧水平变化是血流紊乱导致组织缺氧和血管内皮生长因子(VEGF)产生的结果。
  • 在萎缩性疾病如视网膜色素变性和青光眼中,视网膜氧消耗降低,视网膜血氧测定可检测到此变化。
  • 视网膜血氧测定与视野损害和视网膜萎缩相关,是视网膜萎缩程度的客观代谢指标。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Biomarkers for several eye and brain diseases are reviewed, where retinal oximetry may help confirm diagnosis or measure severity of disease. These include diabetic retinopathy, central retinal vein occlusion (CRVO), retinitis pigmentosa, glaucoma, and Alzheimer's disease. METHODS: Retinal oximetry is based on spectrophotometric fundus imaging and measures oxygen saturation in retinal arterioles and venules in a noninvasive, quick, safe manner. Retinal oximetry detects changes in oxygen metabolism, including those that result from ischemia or atrophy. RESULTS: In diabetic retinopathy, venous oxygen saturation increases and arteriovenous difference decreases. Both correlate with diabetic retinopathy severity as conventionally classified on fundus photographs. In CRVO, vein occlusion causes hypoxia, which is measured directly by retinal oximetry to confirm the diagnosis and measure severity. In both diseases, the change in oxygen levels is a consequence of disturbed blood flow with resulting tissue hypoxia and vascular endothelial growth factor (VEGF) production. In atrophic diseases, such as retinitis pigmentosa and glaucoma, retinal oxygen consumption is reduced and this is detected by retinal oximetry. Retinal oximetry correlates with visual field damage and retinal atrophy. It is an objective metabolic measure of the degree of retinal atrophy. Finally, the retina is part of the central nervous system tissue and reflects central nervous system diseases. In Alzheimer's disease, a change in retinal oxygen metabolism has been discovered. CONCLUSIONS: Retinal oximetry is a novel, noninvasive technology that opens the field of metabolic imaging of the retina. Biomarkers in metabolic, ischemic, and atrophic diseases of the retina and central nervous system have been discovered.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Stefánsson E, Olafsdottir OB, Einarsdottir AB, et al. Retinal Oximetry Discovers Novel Biomarkers in Retinal and Brain Diseases. Invest Ophthalmol Vis Sci. 2017. PMID: 28810002. doi:10.1167/iovs.17-21776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。